These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2861678)

  • 21. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Withdrawal of preparations blocking beta-adrenergic receptors].
    Prichard BN; Bhattacharjee P; Tomlinson B; Walden RJ
    Ter Arkh; 1982; 54(11):38-45. PubMed ID: 6130620
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute beta-blocker withdrawal and exchange by verapamil before percutaneous transluminal angioplasty.
    Mossier M; Hasin Y; Gotsman MS
    Artery; 1988; 15(3):118-21. PubMed ID: 2896493
    [No Abstract]   [Full Text] [Related]  

  • 24. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Arrhythmic syndrome and sudden death in hypertrophic cardiomyopathy].
    Storozhakov GI; Selivanov AI; Kisliak OA
    Ter Arkh; 1988; 60(8):137-41. PubMed ID: 2906486
    [No Abstract]   [Full Text] [Related]  

  • 26. [Risks in sudden withdrawal of beta-blocking drugs--beta-blockade withdrawal syndrome].
    Kristensen BO
    Ugeskr Laeger; 1978 Sep; 140(39):2357-60. PubMed ID: 29369
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of propranolol withdrawal on the induction of sudden death in chronically infarcted rats by isoproterenol challenge].
    Dai DZ; Kuang LX; Chen L; Huang ML; Zhang DL; Zhang XA
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):242-7. PubMed ID: 2959021
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-blocker withdrawal: the song of Orpheus.
    Eichhorn EJ
    Am Heart J; 1999 Sep; 138(3 Pt 1):387-9. PubMed ID: 10467182
    [No Abstract]   [Full Text] [Related]  

  • 29. beta-Blockers and myocardial infarction.
    Moser M; Gorlin R
    Arch Intern Med; 1982 Sep; 142(9):1618-9. PubMed ID: 6126165
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-adrenergic blockers].
    Belovezhdov N
    Vutr Boles; 1986; 25(4):14-22. PubMed ID: 2876553
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of risk factors in sudden death after myocardial infarction. I. Arrhythmias in asymptomatic patients before discharge from the hospital].
    Dłuzniewski M
    Kardiol Pol; 1987; 30(1):9-14. PubMed ID: 3613401
    [No Abstract]   [Full Text] [Related]  

  • 32. Withdrawal syndromes and the cessation of antihypertensive therapy.
    Hart GR; Anderson RJ
    Arch Intern Med; 1981 Aug; 141(9):1125-7. PubMed ID: 6114720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which beta-blocker?
    Med Lett Drugs Ther; 2001 Feb; 43(1097):9-11. PubMed ID: 11177223
    [No Abstract]   [Full Text] [Related]  

  • 34. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
    Frishman W; Silverman R; Strom J; Elkayam U; Sonnenblick E
    Am Heart J; 1979 Aug; 98(2):256-62. PubMed ID: 36744
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of risk factors in sudden cardiac death after myocardial infarction. II. Late ventricular potentials, rhythm disorders and myocardial damage].
    Dłuzniewski M; Kułakowski P; Grochowicz U; Budaj A; Senatorski M
    Kardiol Pol; 1987; 30(2):80-7. PubMed ID: 3626263
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differential therapeutic aspects of high blood pressure therapy with beta blockers].
    Bühler FR; Bolli P
    Schweiz Rundsch Med Prax; 1983 May; 72(20):684-90. PubMed ID: 6136031
    [No Abstract]   [Full Text] [Related]  

  • 38. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac death prevention in post-myocardial infarction patients: a review.
    Boissel JP; Leizorovicz A; Faucomprez C
    Acta Cardiol Suppl; 1980; (25):147-79. PubMed ID: 6103625
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.